This article first appeared on GuruFocus.

NYAB AB (OSTO:NYAB) is set to release its Q3 2025 earnings on Nov 5, 2025. The consensus estimate for Q3 2025 revenue is $1.63 billion, and the earnings are expected to come in at $0.11 per share. The full year 2025's revenue is expected to be $5.98 billion and the earnings are expected to be $0.33 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 7 Warning Signs with BCO.

Is OSTO:NYAB fairly valued? Test your thesis with our free DCF calculator.

Revenue estimates for NYAB AB (OSTO:NYAB) have increased from $5.75 billion to $5.98 billion for the full year 2025 and increased from $6.27 billion to $6.55 billion for 2026 over the past 90 days. Earnings estimates for NYAB AB (OSTO:NYAB) have remained flat at $0.33 per share for the full year 2025 and at $0.44 per share for 2026 over the past 90 days.

In the previous quarter of 2025-06-30, NYAB AB's (OSTO:NYAB) actual revenue was $1.48 billion, which beat analysts' revenue expectations of $1.34 billion by 10.82%. NYAB AB's (OSTO:NYAB) actual earnings were $0.11 per share, which met analysts' earnings expectations. After releasing the results, NYAB AB (OSTO:NYAB) was up by 5.01% in one day.

Based on the one-year price targets offered by 1 analyst, the average target price for NYAB AB (OSTO:NYAB) is $8.26 with a high estimate of $8.26 and a low estimate of $8.26. The average target implies an upside of 25.76% from the current price of $6.57.

Based on GuruFocus estimates, the estimated GF Value for NYAB AB (OSTO:NYAB) in one year is $0, suggesting a downside of -100% from the current price of $6.57.

Based on the consensus recommendation from 1 brokerage firm, NYAB AB's (OSTO:NYAB) average brokerage recommendation is currently 2.0, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.